Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Alpha-1 Antitrypsin in AAT Deficiency
NCT02001688Phase 2Completed
- Sponsor
- Kamada Ltd.
- Start
- Apr 2014
- Primary completion
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of alpha1-proteinase inhibitor (human) in alpha-1 antitrypsin deficiency (AATD), sponsored by Kamada Ltd.. Started Apr 2014; status: completed.
02
Drugs
alpha1-proteinase inhibitor (human)
03
Conditions
alpha-1 antitrypsin deficiency (AATD)
Beyond the preview
Go deeper on NCT02001688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02001688.